Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  WebMD Health Corp.    WBMD

Delayed Quote. Delayed  - 07/01 09:59:57 pm
58.38 USD   +0.46%
06/20 WEBMD HEALTH : Announces 2016 People's Choice Award Nominees for Ann..
06/01 WEBMD HEALTH : Closes Offering of 2.625% Convertible Notes Due 2023
05/27 WEBMD HEALTH : Announces the Exercise of the Over-Allotment Option f..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales515580636703770819
Operating income (EBITDA)84,3159193225257282
Operating profit (EBIT)57,796,3129161189209
Pre-Tax Profit (EBT)28,8-----
Net income15,142,178,188,9107136
P/E ratio12739,632,631,126,918,6
EPS ( $ )0,311,001,481,872,163,12
Dividend per Share ( $ )------
Yield------
Reference price ( $ )39.539.5548.358.1158.1158.11
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt127245162---
Finance---1,16136283
Operating income (EBITDA)84,3159193225257282
Leverage
(Debt/EBITDA)
1,51x1,55x0,84x---
Capital Expenditure-23,248,431,432,233,0
Book Value Per Share (BVPS)4,25 $-----
Cash Flow per Share------
Announcement Date02/20/2014
09:00pm
02/24/2015
09:00pm
02/23/2016
09:01pm
---
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 2 248 M$ -
Entreprise Value (EV) 2 247 M$ 2 112 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 31,1x 26,9x
Capitalization / Revenue 3,20x 2,92x
EV / Revenue 3,19x 2,74x
EV / EBITDA 10,00x 8,23x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 22,9% 24,6%
operating Leverage (Delta EBIT / Delta Sales) 2,36x 1,86x
Net Margin (Net Profit / Revenue) 12,6% 13,9%
ROA (Net Profit / Asset) 7,50% 9,10%
ROE (Net Profit / Equities) 45,9% 42,9%
Rate of Dividend - -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   4,46% 4,18%
Cash Flow / Sales - -
Capital Intensity (Assets / Sales) 1,69x 1,53x
Financial Leverage (Net Debt / EBITDA) -0,01x -0,53x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend